(Q36966069)

English

Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention

scientific article published on November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention (English)

1 reference

Europe PubMed Central

17 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

Elizabeth Selvin

2

object named as

Elizabeth Selvin

1 reference

Europe PubMed Central

17 August 2017

author name string

Sherita H Golden

1

1 reference

Europe PubMed Central

17 August 2017

Kayla E Cunningham

3

1 reference

Europe PubMed Central

17 August 2017

publication date

1 November 2007

1 reference

Europe PubMed Central

17 August 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

17 August 2017

9

1 reference

Europe PubMed Central

17 August 2017

6

1 reference

Europe PubMed Central

17 August 2017

792-798

1 reference

Europe PubMed Central

17 August 2017

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

The effect of ruboxistaurin on nephropathy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Overview of incretin hormones

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2006.00673.X

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36966069&oldid=1664643842"